Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity
Colin Hutton, Felix Heider, Adrián Blanco‐Gómez, et al.
Cancer Cell (2021) Vol. 39, Iss. 9, pp. 1227-1244.e20
Open Access | Times Cited: 226

Showing 26-50 of 226 citing articles:

Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
Ziyi Li, Rhea Pai, Saurabh Gupta, et al.
Nature Cancer (2024) Vol. 5, Iss. 1, pp. 167-186
Open Access | Times Cited: 29
Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer
Ningning Niu, Xuqing Shen, Zheng Wang, et al.
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 869-884.e9
Closed Access | Times Cited: 24
Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas
Marina T. Broz, Emily Y. Ko, Kristin Ishaya, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 20
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 18
Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer
Jad I. Belle, D. Sen, John Baer, et al.
Cancer Discovery (2024) Vol. 14, Iss. 7, pp. 1324-1355
Closed Access | Times Cited: 16
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities
Qin Qin, Rong Yu, John Eriksson, et al.
Cancer Letters (2024) Vol. 591, pp. 216859-216859
Open Access | Times Cited: 15
Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis‐Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment
Yuan Zhi, Qian Wang, Moxin Zi, et al.
Advanced Science (2024) Vol. 11, Iss. 12
Open Access | Times Cited: 14
Extracellular vesicle–packaged PIAT from cancer-associated fibroblasts drives neural remodeling by mediating m5C modification in pancreatic cancer mouse models
Shangyou Zheng, Chonghui Hu, Qing Lin, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 756
Closed Access | Times Cited: 13
Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation
Yang Gao, Jianan Li, Wenfeng Cheng, et al.
Cancer Cell (2024)
Open Access | Times Cited: 13
WNT-dependent interaction between inflammatory fibroblasts and FOLR2+ macrophages promotes fibrosis in chronic kidney disease
Camille Cohen, Rana Mhaidly, Hugo Croizer, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions
Kelly Boelaars, Ernesto Rodríguez, Zowi R. Huinen, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 12
Macrophage-fibroblast JAK/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer
Meirion Raymant, Yuliana Astuti, Laura Álvaro‐Espinosa, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy
Zhi‐Jian Han, Yang-Bing Li, Luxi Yang, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 137-137
Open Access | Times Cited: 71
Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis
Brian Y. Lee, Elizabeth Hogg, Christopher R. Below, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 65
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting
Utpreksha Vaish, Tejeshwar Jain, Abhi C. Are, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13408-13408
Open Access | Times Cited: 64
Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade
Varintra E. Lander, Jad I. Belle, Natalie L. Kingston, et al.
Cancer Discovery (2022) Vol. 12, Iss. 12, pp. 2774-2799
Open Access | Times Cited: 60
Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging
Agathe Peltier, Romain-David Seban, Irène Buvat, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 262-272
Open Access | Times Cited: 59
Epithelial and stromal co-evolution and complicity in pancreatic cancer
Sunil R. Hingorani
Nature reviews. Cancer (2022) Vol. 23, Iss. 2, pp. 57-77
Open Access | Times Cited: 58
The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth
Paul Manoukian, Maarten F. Bijlsma, Hanneke W.M. van Laarhoven
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 56
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment
Yu-Heng Zhu, Jia-Hao Zheng, Qin-Yuan Jia, et al.
Cellular Oncology (2022) Vol. 46, Iss. 1, pp. 17-48
Closed Access | Times Cited: 53
Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasion
Elizabeth R. Murray, Shinelle Menezes, Jack C. Henry, et al.
Cell Reports (2022) Vol. 38, Iss. 4, pp. 110227-110227
Open Access | Times Cited: 50
Cancer‐associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets
Shinelle Menezes, Mohamed Hazem Okail, Siti Munira Abd Jalil, et al.
The Journal of Pathology (2022) Vol. 257, Iss. 4, pp. 526-544
Open Access | Times Cited: 49
Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context
Samuel A. Kerk, Lin Lin, Amy L. Myers, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 49
Subpopulations of cancer-associated fibroblasts link the prognosis and metabolic features of pancreatic ductal adenocarcinoma
Beiyuan Hu, Chuntao Wu, Huarong Mao, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 5, pp. 262-262
Open Access | Times Cited: 48
Cancer-associated fibroblasts: Vital suppressors of the immune response in the tumor microenvironment
Xuan Xiang, Yiran Niu, Zi-Hao Wang, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 67, pp. 35-48
Closed Access | Times Cited: 45

Scroll to top